MTT5
Product Specifications
SKU
C03622-5mg
Target
TLR
Applications
Immunology & Inflammation
Additionnal Information
MTT5 is an agonist of TLR7 that activates dendritic cells and CD8+ T cells, enhancing immune responses in the tumor microenvironment. When linked to an ADC, it enhances antitumor efficacy through combined immune stimulation and cytotoxicity.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1024344-01 25 mg
7- (6- (2-Hydroxypropan-2-Yl) Pyridin-3-Yl) -1- (Trans-4-Methoxycyclohexyl) -3,4-Dihydropyrazino[2,3-B]Pyrazin-2 (1H) -One
Sign In for Pricing
View Details OR1024344-02 50 mg
7- (6- (2-Hydroxypropan-2-Yl) Pyridin-3-Yl) -1- (Trans-4-Methoxycyclohexyl) -3,4-Dihydropyrazino[2,3-B]Pyrazin-2 (1H) -One
Sign In for Pricing
View Details OR1024344-03 100 mg
7- (6- (2-Hydroxypropan-2-Yl) Pyridin-3-Yl) -1- (Trans-4-Methoxycyclohexyl) -3,4-Dihydropyrazino[2,3-B]Pyrazin-2 (1H) -One
Sign In for Pricing
View Details OR1024344-04 250 mg
7- (6- (2-Hydroxypropan-2-Yl) Pyridin-3-Yl) -1- (Trans-4-Methoxycyclohexyl) -3,4-Dihydropyrazino[2,3-B]Pyrazin-2 (1H) -One
Sign In for Pricing
View Details 